TORONTO–(BUSINESS WIRE)–Herban Industries CA LLC (“Herban”) today filed suit in the
California Superior Court for the County of San Francisco against Eaze
Technologies, Inc. (“Eaze”) seeking an injunction to halt Eaze’s
processing of credit and debit cards through its website and app. Herban
is a wholly-owned subsidiary of DionyMed Brands Inc. (“DionyMed”
or the “Company“) (CSE: DYME; OTCQB: DYMEF), a multi-state
cannabis brands, distribution and direct-to-consumer delivery platform.
The complaint alleges that “to gain an unfair competitive advantage in
the California cannabis delivery market, Eaze is directing,
coordinating, and participating in a scheme to defraud credit card
companies and financial institutions into processing cannabis
transactions in violation of a host of criminal laws,” including
prohibitions against wire fraud and bank fraud. The complaint alleges
Eaze carries out this conspiracy using offshore payment processors and a
series of shell companies to conceal the cannabis nature of card
purchases made on its platform. As relief, the complaint seeks an
injunction to halt Eaze’s credit and debit card processing and an end to
its unfair competition against Chill, DionyMed’s direct-to-consumer
platform.
About DionyMed
Founded in 2017, DionyMed is a multi-state cannabis brands platform,
supporting cultivators, manufacturers and award-winning brands in the
medical and adult use cannabis markets. DionyMed sells branded products
in every category from flower to vape cartridges, concentrates and
edibles. DionyMed serves cannabis consumers through retail dispensary
distribution and direct-to-consumer fulfillment with its growing
portfolio of award-winning brands. Learn more at dionymed.com and follow
@DYME_Inc on Twitter and LinkedIn.
This news release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities described herein
in the United States. The securities described herein have not been
registered under the United States Securities Act of 1933, as amended
(the “U.S. Securities Act”), or any state securities law and may not be
offered or sold in the “United States”, as such term is defined in
Regulation S promulgated under the U.S. Securities Act, unless
registered under the U.S. Securities Act and applicable state securities
laws or an exemption from such registration requirements is available.
Contacts
Edward Fields, CEO
[email protected]
669-232-5270
Peter Kampian, CFO
[email protected]
647-948-8387
Investor:
Phil Carlson / Erika Kay
KCSA Strategic
Communications
Phone: 212-896-1233
[email protected]
/ [email protected]
Media:
Kate Tumino / Brittany Tibaldi
KCSA Strategic
Communications
212-896-1252 / 347-487-6794
[email protected]
/ [email protected]
